{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:25:55Z","timestamp":1791339955664,"version":"4.3.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana Ricerca Cancro","doi-asserted-by":"crossref","award":["12182"],"award-info":[{"award-number":["12182"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FP7 European Community Grant Cam-Pac","award":["602783"],"award-info":[{"award-number":["602783"]}]},{"name":"Italian Ministry of Health","award":["FIMP-CUP_J33G13000210001"],"award-info":[{"award-number":["FIMP-CUP_J33G13000210001"]}]},{"name":"NIH\/NCI","award":["P50 CA62924"],"award-info":[{"award-number":["P50 CA62924"]}]},{"name":"NIH\/NIDDK","award":["K08 DK107781"],"award-info":[{"award-number":["K08 DK107781"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.humpath.2018.07.006","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T11:58:56Z","timestamp":1532001536000},"page":"157-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications"],"prefix":"10.1016","volume":"81","author":[{"given":"Claudio","family":"Luchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Cros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Pilati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borislav","family":"Rusev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mafficini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Nottegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewijk A.A.","family":"Brosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00ebl","family":"No\u00eb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Johan A.","family":"Offerhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Chianchiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Parolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Malleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita T.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Corbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Sperandio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Barbareschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Fassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura D.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2018.07.006_bb0005","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2018.07.006_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.humpath.2018.07.006_bb0015","series-title":"WHO Classification of Tumours of the Digestive System","author":"Bosman","year":"2010"},{"key":"10.1016\/j.humpath.2018.07.006_bb0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.path.2016.05.003","article-title":"Pancreatic ductal adenocarcinoma and its variants","volume":"9","author":"Luchini","year":"2016","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.humpath.2018.07.006_bb0025","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.humpath.2018.07.006_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2018.07.006_bb0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/path.4941","article-title":"Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma","volume":"243","author":"Luchini","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2018.07.006_bb0040","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/PAS.0000000000000689","article-title":"Undifferentiated carcinoma with osteoclastic giant cells of the pancreas: clinicopathologic analysis of 38 cases highlights a more protracted clinical course than currently appreciated","volume":"40","author":"Muraki","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.07.006_bb0045","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/annonc\/mdw181","article-title":"Biomarkers associated with checkpoint inhibitors","volume":"27","author":"Manson","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2018.07.006_bb0050","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and biochemical aspects of the PD-1 checkpoint pathway","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2018.07.006_bb0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.canlet.2017.08.006","article-title":"PD-1\/PD-L1 and immunotherapy for pancreatic cancer","volume":"407","author":"Feng","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.humpath.2018.07.006_bb0060","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdv615","article-title":"Regulation of PD-L1: a novel role of pro-survival signalling in cancer","volume":"27","author":"Chen","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2018.07.006_bb0065","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ijc.28736","article-title":"Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis","volume":"135","author":"Helm","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2018.07.006_bb0070","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1007\/s13277-015-4741-z","article-title":"The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer","volume":"37","author":"Hu","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.humpath.2018.07.006_bb0075","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jss.2009.05.026","article-title":"Significance of M2-polarized tumor associated macrophage in pancreatic cancer","volume":"167","author":"Kurahara","year":"2009","journal-title":"J Surg Res"},{"issue":"6","key":"10.1016\/j.humpath.2018.07.006_bb0080","first-page":"383","article-title":"CD71 in gestational pathology: a versatile immunohistochemical marker with new possible applications","volume":"26","author":"Luchini","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2018.07.006_bb0085","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.placenta.2015.09.012","article-title":"Specific expression patterns of epithelial to mesenchymal transition factors in gestational molar disease","volume":"36","author":"Luchini","year":"2015","journal-title":"Placenta"},{"issue":"6","key":"10.1016\/j.humpath.2018.07.006_bb0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAI.0000000000000440","article-title":"Pulmonary adenocarcinoma with enteric differentiation: immunohistochemistry and molecular morphology","volume":"26","author":"Nottegar","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2018.07.006_bb0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/his.13254","article-title":"PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions","volume":"71","author":"Saraggi","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2018.07.006_bb0100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pathol.2016.10.015","article-title":"Enhanced expression of programmed cell death 1 (PD-1) protein in benign vascular anomalies","volume":"49","author":"Amaya","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2018.07.006_bb0105","doi-asserted-by":"crossref","first-page":"26845","DOI":"10.18632\/oncotarget.15839","article-title":"PD-L1 expression and its relationship with oncogenic drivers in non\u2013small cell lung cancer (NSCLC)","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.07.006_bb0110","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1309\/QHD6YFN81KQXUUH6","article-title":"CD163: a specific marker of macrophages in paraffin-embedded tissue samples","volume":"122","author":"Lau","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.07.006_bb0115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1158\/1078-0432.CCR-15-0715","article-title":"PD-L1 and HLA class I antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma","volume":"22","author":"Sabbatino","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2018.07.006_bb0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ajcp\/aqx092","article-title":"Undifferentiated pancreatic carcinomas display enrichment for frequency and extent of PD-L1 expression by tumor cells","volume":"148","author":"Lehrke","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.07.006_bb0125","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/cam4.1087","article-title":"The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer","volume":"6","author":"Imai","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.humpath.2018.07.006_bb0130","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1186\/s12885-017-3634-5","article-title":"Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma","volume":"17","author":"Tessier-Cloutier","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2018.07.006_bb0135","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.18632\/oncotarget.14069","article-title":"Prognostic value and clinicopathological features of PD-1\/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancreatic cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.07.006_bb0140","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2018.07.006_bb0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2016.05.001","article-title":"Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status","volume":"97","author":"Cha","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.humpath.2018.07.006_bb0150","doi-asserted-by":"crossref","first-page":"692","DOI":"10.21037\/tcr.2016.11.76","article-title":"Regulation of cytotoxic T-cell responses by p53 in cancer","volume":"5","author":"Braun","year":"2016","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.humpath.2018.07.006_bb0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2018.07.006_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050946","article-title":"Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2018.07.006_bb0165","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20080108","article-title":"\u201cRe-educating\u201d tumor-associated macrophages by targeting NF-kappaB","volume":"205","author":"Hagemann","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.humpath.2018.07.006_bb0170","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.1021\/acs.nanolett.7b03756","article-title":"Reprogramming tumor-associated macrophages to reverse EGFRT790M resistance by dual-targeting codelivery of gefitinib\/vorinostat","volume":"17","author":"Peng","year":"2017","journal-title":"Nano Lett"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718302648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718302648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:35:13Z","timestamp":1758645313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817718302648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":34,"alternative-id":["S0046817718302648"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2018.07.006","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2018.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}